OSAM
RAPT

O'Shaughnessy Asset Management’s RAPT Therapeutics RAPT Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-75
Closed -$19K – 2197
2021
Q3 		$19K Hold
75
– – ﹤0.01% 1961
2021
Q2 		$19K Hold
75
– – ﹤0.01% 1858
2021
Q1 		$13K Hold
75
– – ﹤0.01% 1732
2020
Q4 		$12K Buy
+75
New +$16.3K ﹤0.01% 1522

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

O'Shaughnessy Asset Management's RAPT Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of RAPT Therapeutics (RAPT) in Q4 2021, closing a stake of 75 shares — an estimated $19K sold.

O'Shaughnessy Asset Management first reported a position in RAPT in Q4 2020 and held it in 4 quarters. The position peaked at $19K in Q3 2021. 99 funds tracked by Wall St. Rank hold RAPT as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining RAPT Therapeutics position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 75 RAPT Therapeutics shares in Q4 2021, an estimated $19K.
  • O'Shaughnessy Asset Management first reported a position in RAPT Therapeutics in Q4 2020 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's RAPT Therapeutics position peaked at $19K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.